Supplements · Metabolic & Cardiometabolic

garlic decreases blood pressure

In plain terms: Does garlic lower blood pressure?

Strong support Supplements 🔬 Includes disconfirming

RefutedContestedStrong support

consensus score 0.93

Yes, modestly — and mainly if your blood pressure is already high. Several meta-analyses show garlic drops systolic pressure by roughly 5–9 mmHg in people with hypertension, but little in those with normal pressure. It's a mild helper, not a replacement for medication.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

14 support 0 contradict 1 tested null 1 mixed · 16 sources, 12 independent groups · 2 superseded — pooled inside a review, counted once

What the evidence shows

Garlic (esp. aged garlic extract) modestly lowers blood pressure, with the effect concentrated in people who already have hypertension; normotensive subgroups show little to no change. Three independent meta-analyses agree on direction.

Cochrane has no ruling yet see how our grade compares ▾

Cochrane · Not stated as explicit GRADE rating Not directly comparable

based on only 2 RCTs (87 hypertensive patients), authors emphasize imprecision of effect estimates

“"It appears that garlic reduces mean supine systolic and diastolic blood pressure by approximately 10-12 mmHg and 6-9 mmHg, respectively, over and above the effect of placebo but the confidence intervals for these effect estimates are not precise and this difference in blood pressure reduction falls within the known variability in blood pressure measurements," making it "difficult to determine the true impact of garlic on lowering blood pressure." "There is insufficient evidence to determine if garlic provides a therapeutic advantage versus placebo in terms of reducing the risk of mortality and cardiovascular morbidity in hypertensive patients."”

Not directly comparable: their review asks a different question or reports an outcome we do not grade, so it neither corroborates nor contradicts this claim.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (18)

Source	Grade	Stance	Quality	Finding
Ma X et al 2025 · study_type: meta-analysis	meta-analysis	supports	high	Meta-analysis + trial sequential analysis of 12 placebo-controlled trials (405 garlic vs 333 placebo) in hypertensive patients: SBP mean difference -8.12 mmHg (95% CI -10.95 to -5.28), DBP -4.26 mmHg (95% CI -5.99 to -2.52), both p<0.0001;
Ojo GB et al 2025 · bioRxiv	animal	supports	low	48 Wistar rats, CaCl2-induced hypertension model; garlic extract (vs standard antihypertensive drug) significantly lowered blood pressure vs hypertensive controls, with renoprotective effects noted.
Tang Y et al 2025 · study_type: meta-analysis	meta-analysis	supports	high	Systematic review + meta-analysis (PROSPERO-registered) of 10 RCTs in hypertensives: garlic reduced SBP by -4.21 mmHg (95% CI -5.74 to -2.69) and DBP by -3.13 mmHg (95% CI -4.42 to -1.84) vs control, plus HDL up and TNF-a down.
Ziaei S et al. 2001 · Eur J Obstet Gynecol Reprod Biol	RCT	tested-null	moderate	RCT n=100 preeclampsia-risk pregnant women: garlic 800mg - NO significant SBP/DBP/MAP difference (different population).
Wang HP et al. 2015 · J Clin Hypertens	meta-analysis	supports	high	Meta 17 RCTs: SBP -3.75 / DBP -3.39 mmHg; significant SBP drop only in hypertensives (-4.4), not normotensives.
Sobenin IA et al. 2009 · Hypertens Res	RCT	supports	moderate	RCT n=84: time-released Allicor SBP -7.0/DBP -3.8; Kwai SBP -5.4 (DBP ns).
Kwak JS et al. 2014 · Nutr Res Pract	meta-analysis	supports	moderate	Meta 9-10 trials: garlic powder SBP -4.34/DBP -2.36 mmHg (mixed population).
Ried K 2016 · J Nutr	meta-analysis	supports	high	Meta-analysis 20 RCTs (n=970): SBP -5.1 / DBP -2.5 mmHg overall; hypertensive subgroup -8.7 / -6.1 mmHg.
Ried K et al. 2010 · Maturitas	RCT	supports	moderate	RCT n=50 treated-uncontrolled hypertensives: AGE 960mg SBP -10.2 mmHg if baseline SBP>=140. (Ried network.) ↩ SUPERSEDED — pooled in the review above, counted once
Bharatbhai PD et al 2026 · study_type: RCT	observational	supports	low	n=200 hypertensive villagers (100 intervention/100 control), raw garlic clove vs no treatment; SBP fell 152.3→128.5 mmHg and DBP 96.8→82.3 mmHg (p<0.001) vs control.
Hesari NG et al 2025 · study_type: RCT	RCT	supports	moderate	RCT, n=97 women with PCOS+metabolic syndrome, garlic tablets (500mg, 2-3mg allicin) vs placebo for 8 weeks; SBP and DBP decreased significantly by 5.2% and 6.1% respectively (p<0.001/0.001) vs placebo.
Xiong XJ et al. 2015 · Phytomedicine	meta-analysis	supports	moderate	Meta 7 RCTs (hypertensives): SBP -6.71/DBP -4.79 mmHg.
Ried K et al. 2012 · Eur J Clin Nutr	RCT	supports	moderate	Dose-response RCT n=79 uncontrolled hypertensives: 2-cap AGE SBP -11.8 mmHg; 1-cap not significant. (Ried network.) ↩ SUPERSEDED — pooled in the review above, counted once
Rohner A et al. 2015 · Am J Hypertens	meta-analysis	supports	moderate	Meta 9 trials (hypertensives): SBP -9.1/DBP -3.8 mmHg; effect shrank in higher-quality sensitivity analysis. (Ried network.)
Serrano JCE et al. 2023 · Nutrients	RCT	mixed	low	Triple-blind RCT, Grade-I hypertensives on drugs: aged black garlic gave a small -1.8 / -1.5 mmHg extra reduction (clinically marginal); no endothelial/inflammatory change.
Ried K et al. 2008 · BMC Cardiovasc Disord	meta-analysis	supports	high	Meta 11 RCTs: SBP -4.6 overall; hypertensive subgroup -8.4/-7.3 mmHg. (Ried network.)
Silagy CA, Neil HA 1994 · J Hypertens	meta-analysis	supports	moderate	Earliest meta (8 RCTs, Kwai powder): modest BP reduction but authors judged evidence insufficient for routine clinical use - cautious positive.
Reinhart KM et al. 2008 · Ann Pharmacother	meta-analysis	supports	high	Meta 10 trials: elevated-SBP subgroup SBP -16.3/DBP -9.3 mmHg; no effect if BP not elevated.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.